Education
About Us
Working with TipRanks
Follow Us
Sinopharm Group Co Class H (HK:1099)
OTHER OTC:1099
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 584.51B | ¥ 596.57B | ¥ 552.15B | ¥ 521.05B | ¥ 456.41B |
| Gross Profit | ¥ 44.26B | ¥ 48.51B | ¥ 47.43B | ¥ 44.05B | ¥ 40.32B |
| Operating Income | ¥ 16.19B | ¥ 20.21B | ¥ 20.60B | ¥ 19.71B | ¥ 17.76B |
| EBITDA | ¥ 20.17B | ¥ 26.90B | ¥ 26.25B | ¥ 24.68B | ¥ 22.62B |
| Net Income | ¥ 7.05B | ¥ 9.05B | ¥ 8.53B | ¥ 7.76B | ¥ 7.19B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 54.31B | ¥ 63.81B | ¥ 55.22B | ¥ 43.54B | ¥ 50.22B |
| Total Assets | ¥ 392.83B | ¥ 383.39B | ¥ 364.78B | ¥ 335.41B | ¥ 311.24B |
| Total Debt | ¥ 76.39B | ¥ 73.78B | ¥ 69.59B | ¥ 68.37B | ¥ 68.53B |
| Net Debt | ¥ 22.07B | ¥ 9.97B | ¥ 14.37B | ¥ 24.84B | ¥ 18.35B |
| Total Liabilities | ¥ 266.14B | ¥ 263.08B | ¥ 254.71B | ¥ 235.76B | ¥ 221.29B |
| Stockholders' Equity | ¥ 78.88B | ¥ 74.58B | ¥ 68.07B | ¥ 61.89B | ¥ 56.36B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 9.58B | ¥ 14.84B | ¥ 18.55B | ¥ 7.05B | ¥ 9.07B |
| Operating Cash Flow | ¥ 11.55B | ¥ 17.17B | ¥ 20.96B | ¥ 9.31B | ¥ 11.15B |
| Investing Cash Flow | ¥ -3.75B | ¥ -944.53M | ¥ -3.59B | ¥ -1.27B | ¥ -2.20B |
| Financing Cash Flow | ¥ -17.29B | ¥ -7.64B | ¥ -5.69B | ¥ -14.69B | ¥ 2.03B |